Press Releases

Press Releases

Acerus Pharmaceuticals Corporation today announced the signing of an agreement granting the exclusive right to market NATESTO® in South Korea to Hyundai Pharm Co., LTD., a South Korean pharmaceutical company. NATESTO® is the first and only testosterone nasal gel for androgen replacement therapy in adult males for conditions associated with…

Press Releases

Ability Pharmaceuticals, a drug development biopharmaceutical company specialized in oncology, announced today that it has received from the US Food and Drug Administration (FDA), orphan-drug designation (ODD) for ABTL0812, for the treatment of pancreatic cancer. This regulatory milestone comes after the ODD in the pediatric cancer neuroblastoma granted by EMA…

Press Releases

VistaGen Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing new generation therapies for depression and other central nervous system (CNS) disorders, today announced it has signed an exclusive sublicense agreement with BlueRock Therapeutics, a stem cell research company established by Bayer AG and Versant Ventures, for VistaGen's rights to…

Press Releases

Exito Media Concepts Pvt. Ltd. recently conducted the 5th edition of the Pharma Innovation & Technology summit along with the Pharma CIO awards 2016 on 8th December at the JW Marriott in Juhu, Mumbai. The conference was a showcase of best practices and IT innovations implemented by the leaders of…

Press Releases

Bristol-Myers Squibb Company announced important changes to its U.S. geographic footprint that will strengthen capabilities of the company's R&D hubs of world-class science and innovation in Central New Jersey, the San Francisco Bay Area and Cambridge, Massachusetts while further integrating biologics development with clinical manufacturing at key sites to foster…

Press Releases

Johnson & Johnson today confirmed it has ended discussions with Actelion Pharmaceuticals Ltd. (SIX: ATLN) regarding a potential transaction. Johnson & Johnson was not able to reach an agreement that it believed would create adequate value for its shareholders. About Johnson & Johnson Caring for the world, one person at…

Press Releases

Eurofins Genomics today announced the U.S. launch of its EXTREmer oligonucleotides, extremely long oligos that are developed using high-fidelity synthesis chemistry on the company's new DNA synthesis platform. Designed for synthetic biology, next-generation DNA sequencing and other growing applications, these oligos are provided at low yield and with low error…

Press Releases

Today, Alvogen has launched the first generic equivalent to Tamiflu® (oseltamivir phosphate) capsules in the United States. Alvogen expects the generic equivalent to Tamiflu® capsules to deliver significant savings for patients and health providers of up to $500 million during this upcoming season. The product is available in three strengths…

Press Releases

Seattle Genetics, Inc., a global biotechnology company, today presented data from an ongoing phase 1 clinical trial evaluating SGN-LIV1A for patients with metastatic breast cancer (MBC), with particular focus on triple-negative MBC (TN MBC), at the 39th San Antonio Breast Cancer Symposium (SABCS) taking place in San Antonio, Texas, December…

Press Releases

Valeant Pharmaceuticals International, Inc. today announced positive results from a Phase 3, multicenter double-blind, randomized, vehicle-controlled clinical study to assess the safety and efficacy of IDP-118 (halobetasol propionate and tazarotene) lotion in the treatment of plaque psoriasis. Within the Phase 3 study of 215 adult subjects with moderate to severe…